Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CRKL |
| Upstream (Parents) |
|---|
| (<<) DHX9 → CRKL |
| (<<) JAK1 → CRKL |
| (<<) JUNB → CRKL |
| (<<) LPIN1 → CRKL |
| (<<) MAPK14 → CRKL |
| (<<) RAB5A → CRKL |
| (<<) SLC29A1 → CRKL |
| (<<) STAT1 → CRKL |
| Downstream (Children) |
|---|
| CRKL → ATF2 (>>) |
| CRKL → ATP2A2 (>>) |
| CRKL → COTL1 (>>) |
| CRKL → CPD (>>) |
| CRKL → EML4 (>>) |
| CRKL → ERBB3 (>>) |
| CRKL → GNA13 (>>) |
| CRKL → GNAQ (>>) |
| CRKL → MAP3K2 (>>) |
| CRKL → MAPK1 (>>) |
| CRKL → NLGN4Y (>>) |
| CRKL → PTPN11 (>>) |
| CRKL → RB1 (>>) |
| CRKL → ROBO3 (>>) |
| CRKL → SDK2 (>>) |
| CRKL → UBE2J1 (>>) |
